Oxford University Press

SHERPA: Yellow

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Mellinghoff
    Mellinghoff
  4. Shuman
    Shuman
  5. Rosenblum
    Rosenblum
  6. Dunkel
    Dunkel
  7. Karajannis
    Karajannis
  8. Saltz
    Saltz
  9. Souweidane
    Souweidane
  10. Panageas
    Panageas

Groups

  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)
  7. Department of Pathology and Laboratory Medicine (415)
  8. Gastrointestinal Oncology Service (386)
  9. Genitourinary Oncology Service (367)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2131)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (92)
  5. Editorial (84)
  6. Guidelines (36)
  7. Correspondence (26)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (10)
Groups
  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Stewart Shuman (88)
  6. Marc Rosenblum (87)

More People

Years
  1. 2025 (129)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1670)
  2. Neuro-Oncology (855)
  3. JNCI: Journal of the National Cancer Institute (492)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (140)
  6. American Journal of Clinical Pathology (106)

More Publications

Results (4676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • LIBRETTO-531: Selpercatinib in patients with treatment (Tx)-naive RET-mutant medullary thyroid cancer (MTC)
    Meeting Abstract

    Hernando, J.; Tarasova, V.; Hu, M. I.; Sherman, E. J.; Brose, M. S.; Robinson, B.; Tahara, M.; Wirth, L. J.; Sashegyi, A.; Soldatenkova, V.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • TransFAL: Establishment of clinical trial-matched luminal breast cancer patient-derived xenografts (PDX) for translational studies
    Meeting Abstract

    Palafox, M.; Mina, L.; Malfettone, A.; Monserrat, L.; Rodriguez, M. J.; Rodríguez, O.; Guzmán, M.; Grueso, J.; Scaltriti, M.; Miquel, T.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • A pan-cancer analysis of double PIK3CA mutations
    Meeting Abstract

    Vasan, N.; Sivakumar, S.; Jin, D.; Ross, J. S.; Cantley, L. C.; Scaltriti, M.; Sokol, E. S.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Electro-acupuncture for quality of life in gastric cancer patients undergoing adjuvant chemotherapy
    Meeting Abstract

    Zhang, H. B.; Zhu, Y. J.; Mao, J. J.; Peng, J. J.; Chang, X. S.; Wu, X. Y.; Wan, J.; Wang, W.; Diao, D. C.; Xiao, J.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Randomized phase II study of radiation therapy and paclitaxel with pazopanib or placebo: NRG-RTOG 0912
    Meeting Abstract

    Sherman, E. J.; Harris, J.; Bible, K. C.; Xia, P.; Ghossein, R. A.; Chung, C. H.; Riaz, N.; Gunn, B.; Foote, R. L.; Yom, S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Larotrectinib treatment of advanced TRK fusion thyroid cancer
    Meeting Abstract

    Cabanillas, M. E.; Drilon, A.; Farago, A. F.; Brose, M. S.; McDermott, R.; Sohal, D.; Oh, D. Y.; Almubarak, M.; Bauman, J.; Chu, E.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • A multicenter, open-label, randomized phase II study to compare the efficacy and safety of lenvatinib in combination with ifosfamide and etoposide versus ifosfamide and etoposide in children, adolescents and young adults with relapsed or refractory osteosarcoma (OLIE; ITCC-082)
    Meeting Abstract

    Gaspar, N.; Campbell-Hewson, Q.; Bielack, S. S.; Campbell, M.; Bautista, F.; Meazza, C.; Janeway, K.; Dela Cruz, F. S.; Whittle, S. B.; Morgenstern, D. A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Phase Ib expansion study of adavosertib plus olaparib in patients with extensive-stage or relapsed small cell lung cancer
    Meeting Abstract

    Li, B. T.; Hamilton, E. P.; Wang, J. S.; Falchook, G. S.; Oza, A. M.; Rodrigo Imedio, E.; Kumar, S.; Mugundu, G. M.; De Bruin, E.; Spigel, D. R.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Health-related quality of life (HRQoL) in KEYNOTE-604: Pembrolizumab (pembro) or placebo added to etoposide and platinum (EP) as first-line therapy for ES-SCLC
    Meeting Abstract

    Kim, H. R.; Awad, M. M.; Navarro, A.; Gottfried, M.; Peters, S.; Csoszi, T.; Cheema, P. K.; Rodriguez-Abreu, D.; Wollner, M.; Yang, J. C. H.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Long-term efficacy, tolerability and overall survival in patients (pts) with unresectable or metastatic (U/M) PDGFRA D842V-mutant gastrointestinal stromal tumour (GIST) treated with avapritinib: NAVIGATOR phase I trial update
    Meeting Abstract

    Jones, R. L.; Serrano, C.; von Mehren, M.; George, S.; Heinrich, M.; Kang, Y. K.; Schoeffski, P.; Cassier, P.; Mir, O.; Chawla, S. P.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save